Meridia (Sibutramine Hydrochloride) - Summary

MERIDIA SUMMARY

MERIDIA® (sibutramine hydrochloride monohydrate) is an orally administered agent for the treatment of obesity.

MERIDIA is indicated for the management of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a reduced calorie diet. MERIDIA is recommended for obese patients with an initial body mass index >/=30 kg/m², or >/=27 kg/m² in the presence of other risk factors (e.g., hypertension, diabetes, dyslipidemia).

MERIDIA NEWS HIGHLIGHTS

Media Articles Related to Meridia (Sibutramine)

Synthroid and Meridia
Source: MedicineNet levothyroxine sodium Specialty [2006.11.14]

more>>

Published Studies Related to Meridia (Sibutramine)

Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. [2008.01]

Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. [2007.11]

Orlistat and sibutramine beyond weight loss. [2007.10.08]

Long-term persistence with orlistat and sibutramine in a population-based cohort. [2007.10]

Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study. [2007.07]

more>>

Clinical Trials Related to Meridia (Sibutramine)

Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes

A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder

A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.

Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates

Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS

more>>